Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
07/2006
07/04/2006US7070977 Human serine protease D-G polypeptide
07/04/2006US7070974 Polymerase chain reactions; cloning; screening Dna libraries; fusion protein in Escherichia; forming antibodies; isolated nucleic acid
07/04/2006US7070971 enzyme inhibitor for selectin mediated binding events and methods of treating disease conditions using animal models; genetic engineering
07/04/2006US7070970 Nutrients, animal feeds, cosmetics; elongation of polyunsaturated fatty acid
07/04/2006US7070963 Amidase from variovorax
07/04/2006US7070960 Forming monoclonal antibodies; hybridomas culture; variations in concentration of solute; monitoring gene expression
07/04/2006US7070956 Peptides and derivatives thereof showing cell attachment, spreading and detachment activity
07/04/2006US7070955 Comprises nucleotide sequences coding membrane proteins for diagnosing, preventing and treating inflammatory, cell proliferative and autoimmune diseases
07/04/2006US7070947 Human protein kinase, phosphatase, and protease family members and uses thereof
07/04/2006US7070946 Polypeptide for use in the diagnosis and treatment of bone disorders
07/04/2006US7070945 Process for determining the presence of monomeric brain associated human glutamine synthetase in patients exhibiting mild cognitive impairment
07/04/2006US7070944 System for screening fatty acid transport inhibitors, methods of use and modulators identified thereby
07/04/2006US7070942 Method of inducing or enhancing chondrogenesis with extracellular matrix containing GDF-5
07/04/2006US7070930 Chimeric vectors comprising a phage packaging site and a portion derived from the genome of a eukaryotic virus
07/04/2006US7070793 Antigen protein and nucleic acid coding for said protein
07/04/2006US7070792 Chlamydia antigens and corresponding DNA fragments and uses thereof
07/04/2006US7070784 Method for down-regulating GDF-8 activity using immunogenic GDF-8 analogues
07/04/2006US7070771 Methods of expressing chimeric mouse and human CD40 ligand in human CD40+ cells
07/04/2006CA2462725C Defatted canola meal with reduced glucosinolate content
06/2006
06/29/2006WO2006069017A2 Transgenic plants with enhanced agronomic traits
06/29/2006WO2006068975A2 Binding proteins specific for human matriptase
06/29/2006WO2006068972A2 Tissue engineering devices for the repair and regeneration of tissue
06/29/2006WO2006068809A2 Substrate recognition by differentiable human mesenchymal stem cells
06/29/2006WO2006068326A1 Novel polypeptide and the use thereof
06/29/2006WO2006068226A1 Method of separating pancreatic islet
06/29/2006WO2006068225A1 Method of inducing differentiation of skeletal muscle cell
06/29/2006WO2006068148A1 Recombinant microorganism
06/29/2006WO2006067913A1 Method of preparing antibody by use of cell having its fucose transporter function inhibited
06/29/2006WO2006067847A1 Method of preparing antibody by use of cell having its fucose transporter function inhibited
06/29/2006WO2006067210A1 Bcma polypeptides and uses thereof
06/29/2006WO2006066498A1 The transcription factor gene osnacx from rice and use for improving tolerance of plants to drought and salt thereof
06/29/2006WO2006066385A1 Retractable tool and method for manipulating developmental cells in a process of cryopreservation
06/29/2006WO2006066334A1 Potassium channels in human heart
06/29/2006WO2006066320A1 Differentiation of human embryonic stem cells and cardiomyocytes and cardiomyocyte progenitors derived therefrom
06/29/2006WO2006042558A3 Group 2 mite polypeptide variants
06/29/2006WO2006039671A9 Gene markers of tumor metastasis
06/29/2006WO2006023136A3 A neural stem cell-collagen-bioreactor system to construct a functional embryonic brain-like tissue
06/29/2006WO2006020319A3 Methods and compositions for producing target cell reactive lymphocytes in a subject
06/29/2006WO2006017293A3 Models and methods for nociception, pain transduction, and screening for analgesic compounds
06/29/2006WO2006004950A3 Humanized monoclonal antibody 31.1 as an anticancer agent
06/29/2006WO2005118823A3 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics
06/29/2006WO2005118790A3 Combinatorial marking of cells and cell structures with reconstituted fluorescent proteins
06/29/2006WO2005118782A3 Methods of promoting cardiac cell proliferation
06/29/2006WO2005095652A3 Pnmt as a novel marker for progenitor cells
06/29/2006WO2005042581A8 Modified anti-cd52 antibody
06/29/2006WO2005001050A3 Transcription factors
06/29/2006WO2004089292A3 Immunomodulatory agents for treatment of inflammatory diseases
06/29/2006WO2004066942A3 Purification and uses of dendritic cells and monocytes
06/29/2006WO2003104409A3 Maintenance of islet cells
06/29/2006WO2003091413A3 Expression of polypeptides in chloroplasts, and compositions and methods for expressing same
06/29/2006US20060143743 Hybrid maize 35a30
06/29/2006US20060143739 Useful for modulating transcription of a desired polynucleotide; expression cassette or vector, or inserted into the chromosome or used as an exogenous element to modulate in vivo and in vitro; transgenic plant has increased biomass or higher seed yield
06/29/2006US20060143738 Proteases and methods for producing them
06/29/2006US20060143736 Modulating plant carbon levels
06/29/2006US20060143735 Root active promoters and uses thereof
06/29/2006US20060143734 For transfecting a plant cell, transgenic plant
06/29/2006US20060143732 Plant artificial chromosomes, uses thereof and methods of preparing plant artificial chromosomes
06/29/2006US20060143730 Controlling gene expression of plastids; encoding acetolactate synthase ; herbide resistance to plants; detction targte genes
06/29/2006US20060143729 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics
06/29/2006US20060143728 Maize multidrug resistance-associated protein polynucleotides and methods of use
06/29/2006US20060143727 Glyphosate resistant class i 5-enolpyruvylshikimate-3-phosphate synthase(epsps)
06/29/2006US20060143726 Hydroxypyruvate reductase promoter elements and methods of use thereof in plants
06/29/2006US20060142219 Pharmaceutical compositions comprising an hiv envelope protein and cd4
06/29/2006US20060142200 Compounds and methods for lowering cholesterol levels without inducing hypertrigylceridemia
06/29/2006US20060142199 CD-44 like protein
06/29/2006US20060142196 Soluble GDNFR (Glial-cell Derived Neurotrophic Factor) that retains both ligand binding, and receptor signaling function (via Ret receptor tyrosine kinase) used to impart, restore, or enhance GDNFR alpha -ligand (preferably GDNF) responsiveness to cells; kidney diseases
06/29/2006US20060142188 Monkey alpha-7 nicotinic acetylcholine receptor and methods of use thereof
06/29/2006US20060141625 Expression cassette and vector for transient or stable expression of exogenous molecules
06/29/2006US20060141623 Automated tissue engineering system
06/29/2006US20060141622 Transplantation of human neural cells for treatment of neurodegenerative conditions
06/29/2006US20060141621 Process for producing tissue cell from pluripotent stem cell derived from iris pigment epithelial cell of animal and tissue cell obtained by the process
06/29/2006US20060141620 System and method for forming a cardiac tissue construct
06/29/2006US20060141619 Apparatus and method for machining microchamber for cell culture
06/29/2006US20060141618 Cell separation apparatus
06/29/2006US20060141617 Multilayered microcultures
06/29/2006US20060141602 Packaging of positive-strand RNA virus replicon particles
06/29/2006US20060141601 Detergent; polypeptides
06/29/2006US20060141580 Encoding protein with immunomodulatory activity, antiviral activity, and antitumor activity; treating any Type 1 interferon treatable disease including cancer; determining if a patient will respond to interferon treatment; transgenic animals
06/29/2006US20060141579 Cytokine zcytor17 ligand polynucleotides
06/29/2006US20060141574 Method for producing monoclonal antibodies
06/29/2006US20060141573 Novel tumor necrosis factor receptor homolog and nucleic acids encoding the same
06/29/2006US20060141571 Method for promoting cell growth and increasing the production of the expressed target gene products
06/29/2006US20060141560 Estrogen receptor genes and utilization thereof
06/29/2006US20060141559 Extract from cultured mammalian cell, process for preparation thereof and method of cell-free protein synthesis using the extract
06/29/2006US20060141540 Direct selection of cells by secretion product
06/29/2006US20060141515 Polynucleotides encoding plant cysteine proteases
06/29/2006US20060141455 Gene products differentially expressed in cancerous breast cells and their methods of use
06/29/2006US20060141453 Prokineticin polypeptides, related compositions and methods
06/29/2006US20060141451 Guinea pig proteinase-activated receptor 4 and its activating peptide
06/29/2006US20060141450 isolating a target cell, cellular organelle or virus from a sample using inter alia, non- or low-specific binding between a target cell, cellular organelle or virus with a magnetic microbead
06/29/2006US20060141447 Cell culture media for mammalian cells
06/29/2006US20060141446 Bioreactor apparatus comprising optically opaque and transparent regions for culturing and propgating cells; diagnosing cell proliferative disorders
06/29/2006US20060141045 Isolation of cells or the like from bodily fluids
06/29/2006US20060141042 Hollow nanoparticle having modified cysteine residue and drug with the use thereof
06/29/2006US20060140983 Dendritic cells loaded with heat shocked melanoma cell bodies
06/29/2006US20060140979 Antigenic polypeptides
06/29/2006US20060140978 Constitutive transport enhancer (CTE); Rev Responsive element (RRE); coding sequence for HIV-1 Rev, and a coding sequence for a desired protein that comprises a coding sequence for an HIV structural protein that includes an RRE and at least one CTE; genetic vaccines, gene therapy
06/29/2006US20060140969 Hypoallergenic polypeptides based on fish parvalbumin
06/29/2006US20060140964 Human igm antibody lysing activated lymphocytes under mediation by homologous complement
06/29/2006US20060140954 Novel human protein kinases and protein kinase-like enzymes